Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Chronic total occlusions, a true challenge

Original title: Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. A Report From the NCDR (National Cardiovascular Data Registry). Reference: Emanuel S. Brilakis, et al. JACC Cardiovascular Intervention 2015;8:245-53

Chronic total occlusions (CTO) are present in 20% to 50% of pathological coronary angiograms but, even though this percentage has increased in the past years, PCI is performed in around 4% of this kind of lesions.

This study included 594,510 stable patients; 22,365 of them (3.8%) received CTO PCI. Patients presenting CTO were younger, more frequently men, often with prior infarction, prior PCI and ventricular failure.

Procedural success was lower for CTO (59% vs. 96%; p<0.001), with marked variability in centers and operators. Procedural success was associated to the annual volume of CTO PCIs of operators, 10 being 53%, 62% and 75% (p<0.001). The group requiring vessel revascularization required greater contrast volume and longer fluoroscopy time.

Procedural success also increased with operator experience, 55.5% in 2009 to 61.9% in 2013 (p<0.01). Multivariable analysis associated lower procedural success to age, smoking, previous myocardial infarction, previous CABG, previous peripheral heart disease, right coronary artery CTO target vessel and less operator experience.

Combined events resulted higher in CTO PCIs than in conventional PCIs (1.6% vs. 0.8% p<0.001). More operator experience was associated to a lower events risk.

Conclusion

CTO PCI is not frequent in USA in stable patients and is associated to a lower procedural success and a higher complications rate, compared to outcomes in patients that do not present CTO. Success is associated with patient characteristics and operator experience.

Editorial Comment

When performing CTI success will depend on operator and center. Different studies have shown the benefits of revascularization, especially when it comes to the anterior descending artery.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation– Argentina

Carlos Fava

Previous article
Next article

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...